Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Multiple sclerosis: An old drug plays a new trick.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities.
Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis.
RNF and Betaseron® Tolerability Study (REFORMS)
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Transverse myelitis.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
The safety of exercise training in multiple sclerosis: A systematic review.
The role of mitochondria in axonal degeneration and tissue repair in MS.
Insight into the role of CRMP2 (collapsin response mediator protein 2) in T lymphocyte migration: The particular context of virus infection.
Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.

Pages